This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


4jnl

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
'''Unreleased structure'''
+
{{STRUCTURE_4jnl| PDB=4jnl | SCENE= }}
 +
===Crystal Structure of uPA in complex with its inhibitor 4-bromobenzylamine at pH 7.4===
-
The entry 4jnl is ON HOLD until Paper Publication
+
==Disease==
 +
[[http://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN]] Defects in PLAU are the cause of Quebec platelet disorder (QPD) [MIM:[http://omim.org/entry/601709 601709]]. QPD is an autosomal dominant bleeding disorder due to a gain-of-function defect in fibrinolysis. Although affected individuals do not exhibit systemic fibrinolysis, they show delayed onset bleeding after challenge, such as surgery. The hallmark of the disorder is markedly increased PLAU levels within platelets, which causes intraplatelet plasmin generation and secondary degradation of alpha-granule proteins.<ref>PMID:20007542</ref>
-
Authors: Zhang, X., Jiang, L., Zhao, B., Yuan, C., Huang, M.
+
==Function==
 +
[[http://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN]] Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin.
-
Description: Crystal Structure of uPA in complex with its inhibitor 4-bromobenzylamine at pH 7.4
+
==About this Structure==
 +
[[4jnl]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4JNL OCA].
 +
 
 +
==Reference==
 +
<references group="xtra"/><references/>
 +
[[Category: U-plasminogen activator]]
 +
[[Category: Huang, M.]]
 +
[[Category: Jiang, L.]]
 +
[[Category: Yuan, C.]]
 +
[[Category: Zhang, X.]]
 +
[[Category: Zhao, B.]]
 +
[[Category: Halogen]]
 +
[[Category: Hydrolase-hydrolase inhibitor complex]]
 +
[[Category: Upa]]

Revision as of 09:31, 19 March 2014

Template:STRUCTURE 4jnl

Contents

Crystal Structure of uPA in complex with its inhibitor 4-bromobenzylamine at pH 7.4

Disease

[UROK_HUMAN] Defects in PLAU are the cause of Quebec platelet disorder (QPD) [MIM:601709]. QPD is an autosomal dominant bleeding disorder due to a gain-of-function defect in fibrinolysis. Although affected individuals do not exhibit systemic fibrinolysis, they show delayed onset bleeding after challenge, such as surgery. The hallmark of the disorder is markedly increased PLAU levels within platelets, which causes intraplatelet plasmin generation and secondary degradation of alpha-granule proteins.[1]

Function

[UROK_HUMAN] Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin.

About this Structure

4jnl is a 1 chain structure. Full crystallographic information is available from OCA.

Reference

  1. ↑ Paterson AD, Rommens JM, Bharaj B, Blavignac J, Wong I, Diamandis M, Waye JS, Rivard GE, Hayward CP. Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene. Blood. 2010 Feb 11;115(6):1264-6. doi: 10.1182/blood-2009-07-233965. Epub 2009, Dec 9. PMID:20007542 doi:10.1182/blood-2009-07-233965

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/4jnl"
Personal tools